Esperion Therapeutics
ESPR
#6737
Rank
NZ$0.83 B
Marketcap
$4.23
Share price
2.49%
Change (1 day)
115.34%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): -NZ$62.45 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are NZ$0.27 Billion. In 2023 the company made an earning of -NZ$0.26 Billion, an increase over its 2022 earnings that were of -NZ$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$62.45 Million-75.75%
2023 -NZ$0.26 Billion-15.03%
2022 -NZ$0.31 Billion-20.61%
2021 -NZ$0.39 Billion84.28%
2020 -NZ$0.21 Billion35.75%
2019 -NZ$0.16 Billion-55.71%
2018 -NZ$0.35 Billion19.57%
2017 -NZ$0.29 Billion125.39%
2016 -NZ$0.13 Billion51.43%
2015 -NZ$84.42 Million36.45%
2014 -NZ$61.87 Million43.55%
2013 -NZ$43.1 Million145.26%
2012 -NZ$17.58 Million
2002 -NZ$50.11 Million-7.81%
2001 -NZ$54.35 Million15.03%
2000 -NZ$47.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.9 Billion 1,177.85%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.67 B-1,061.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$2.08 Billion 2,878.03%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$8.51 B-12,310.43%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.18 Billion 145.32%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.35 Billion 396.60%๐Ÿ‡บ๐Ÿ‡ธ USA